| Associate Director, Strategy, Oncology Disease Area |
Cambridge (USA) |
USA |
Biomedical Research |
Research |
BD&L & Strategic Planning |
27 Mei 2026 |
| Executive Director M&A Transactions |
Cambridge (USA) |
USA |
Strategy & Growth |
Finance |
BD&L & Strategic Planning |
27 Mei 2026 |
| Executive Director M&A Transactions |
Basel (City) |
Switzerland |
Strategy & Growth |
Finance |
BD&L & Strategic Planning |
27 Mei 2026 |
| Head of China C&BD |
Shanghai (Shanghai) |
China |
Strategy & Growth |
Strategic Planning & BD&L |
BD&L & Strategic Planning |
26 Mei 2026 |
| VP, M&A Transactions |
Basel (City) |
Switzerland |
Strategy & Growth |
Finance |
BD&L & Strategic Planning |
22 Mei 2026 |
| VP, M&A Transactions |
Cambridge (Massachusetts) |
USA |
Strategy & Growth |
Strategic Planning & BD&L |
BD&L & Strategic Planning |
22 Mei 2026 |
| AI Innovation Lead |
Hyderabad (Office) |
India |
People & Organization |
Human Resources |
BD&L & Strategic Planning |
20 Mei 2026 |
| Director, Portfolio & Product Strategy, NS |
East Hanover |
USA |
US |
General Management |
BD&L & Strategic Planning |
18 Mei 2026 |
| Director, Portfolio & Product Strategy, NS |
East Hanover |
USA |
US |
General Management |
BD&L & Strategic Planning |
18 Mei 2026 |
| Executive Director, Therapeutic Area Strategy, Oncology and Hematology |
East Hanover |
USA |
Strategy & Growth |
Strategic Planning & BD&L |
BD&L & Strategic Planning |
08 Mei 2026 |
| Director, Therapeutic Area Strategy, CRM |
Cambridge (USA) |
USA |
Strategy & Growth |
General Management |
BD&L & Strategic Planning |
28 April 2026 |
| Director, Therapeutic Area Strategy, CRM |
Basel (City) |
Switzerland |
Strategy & Growth |
General Management |
BD&L & Strategic Planning |
28 April 2026 |
| ED, US Business Development and Licensing, Commercial Mergers & Integrations |
East Hanover |
USA |
US |
Strategic Planning & BD&L |
BD&L & Strategic Planning |
28 April 2026 |
| Director, Therapeutic Area Strategy, Immunology |
Basel (City) |
Switzerland |
Strategy & Growth |
Other |
BD&L & Strategic Planning |
27 April 2026 |
| Director, Therapeutic Area Strategy, Immunology |
Cambridge (USA) |
USA |
Strategy & Growth |
Other |
BD&L & Strategic Planning |
27 April 2026 |
| Therapeutic Area Strategy Director, Oncology & Hematology |
East Hanover |
USA |
Strategy & Growth |
Strategic Planning & BD&L |
BD&L & Strategic Planning |
27 April 2026 |
| Therapeutic Area Strategy Director, Oncology & Hematology |
Basel (City) |
Switzerland |
Strategy & Growth |
Strategic Planning & BD&L |
BD&L & Strategic Planning |
27 April 2026 |
| Executive Director, Therapeutic Area Strategy, Oncology and Hematology |
Basel (City) |
Switzerland |
Strategy & Growth |
Strategic Planning & BD&L |
BD&L & Strategic Planning |
21 April 2026 |
| Executive Director, Portfolio & Product Strategy Theranostics |
Distant Employee - Distant Working Arrangement (DWA) (USA) |
USA |
US |
General Management |
BD&L & Strategic Planning |
08 April 2026 |
| Head of New Product, International China |
Shanghai (Shanghai) |
China |
International |
General Management |
BD&L & Strategic Planning |
03 Maart 2026 |